1. he Isolate and Target system of creating singular compounds will not work for Cannabinoid Therapy Application.

    Br J Pharmacol. 2011 Aug; 163(7): 1344–1364.

    PMCID: PMC3165946

    Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects

    Scientific evidence is presented for non-cannabinoid plant components as putative antidotes to intoxicating effects of THC that could increase its therapeutic index. Methods for investigating entourage effects in future experiments will be proposed. Phytocannabinoid-terpenoid synergy, if proven, increases the likelihood that an extensive pipeline of new therapeutic products is possible from this venerable plant.

  2. CBD is NOT the ONLY medicinal component of Cannabis; It is ONE of the medicinal components but they all work together in synergy (THC CBD THCv CBG CNB…..), in conjunction with the terpene profile, to create the entourage healing effect.

    It takes different ratios of the cannabis to treat different ailments but ALL treatments work best when used in 'whole cannabinoid therapy' and not when the cannabinoids are isolated.

  3. Cannabinoids have been ignored as potent medicines due to the pharmaceutical industry’s failure to successfully isolate and synthesize any beneficial individual cannabinoid compounds; They have ignored the synergy and entourage effects of the complex of 100s of Cannabinoids and 100s of terpenes in the Cannabis plant due to the industry wide fixation on the current 'Isolate, Target, Patent for Profit', system of pharmaceutical research.

Leave a Reply

Your email address will not be published.